98%
921
2 minutes
20
Background: Cold chest pack (CCP) is a hydrotherapeutic technique used to improve cardiorespiratory outcomes, however, their effects on the cardiovascular system remain substantiated by credible scientific research. Hence, the present study aimed to evaluate how CCP affects central hemodynamics in healthy volunteers.
Method: This study was a randomized, open-label crossover trial with 24 healthy male participants between 18 and 26 years of age. The study employed a counterbalanced design in which participants were randomized to either a dry chest pack (DCP) or a CCP for 20 minutes, followed by a 2-day washout period during which they were switched to the opposite phase. Central hemodynamics and heart rate variability were measured at baseline, throughout the session, and ten minutes following the intervention.
Results: Our findings showed a significant decrease in cardiac output (P = .03) with an increase in total peripheral resistance (P = .004), mean arterial pressure (P < .001), systolic blood pressure (P < .001), and diastolic blood pressure (P < .001) during the use of a CCP. These changes were retained after 10 minutes, except cardiac output (P = .32), and a persistent decrease in heart rate (P < .001) during and after the CCP use. These changes were not observed in DCP and the stroke volume was not impacted in either group (P > .05). A significant increase in mean RR intervals (P < .001) and the percentage of differences between adjacent normal heartbeats (NN intervals) that are greater than 50 milliseconds (P < .01) was observed only after the application of a CCP.
Conclusion: The results of this study showed the application of a CCP for 20 minutes affects central hemodynamics and heart rate variability; these results may be considered when using CCP therapeutically.
Download full-text PDF |
Source |
---|
Radiology
September 2025
Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Plc, Box 1234, New York, NY 10029.
Background The prognostic value of baseline visual emphysema scoring at low-dose CT (LDCT) in lung cancer screening cohorts is unknown. Purpose To determine whether a single visual emphysema score at LDCT is predictive of 25-year mortality from all causes, chronic obstructive pulmonary disease (COPD), and cardiovascular disease (CVD). Materials and Methods In this prospective cohort study, asymptomatic adults aged 40-85 years with a history of smoking underwent baseline LDCT screening for lung cancer between June 2000 and December 2008.
View Article and Find Full Text PDFChronic Obstr Pulm Dis
August 2025
Lahey Hospital and Medical Center, Lahey UMass-Chan School of Medicine, Burlington, Massachusetts, United States.
Background: Chronic Obstructive Pulmonary Disease (COPD) remains underdiagnosed and undertreated. Because screening asymptomatic individuals for COPD is not recommended, several case-finding tools have been explored. The CAPTURE questionnaire and peak expiratory flow rate (PEFR) (CAPTURE tool) have been tested in the primary care setting, with disappointing results.
View Article and Find Full Text PDFEur Heart J Cardiovasc Imaging
August 2025
Cardiovascular Imaging Research Center (CIRC), Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Aims: Epicardial adipose tissue (EAT) is a metabolically active fat depot associated with coronary atherosclerosis and cardiovascular (CV) risk. While EAT is a known prognostic marker in lung cancer screening, its sex-specific prognostic value remains unclear. This study investigated sex differences in the prognostic utility of serial EAT measurements on low-dose chest CTs.
View Article and Find Full Text PDFPharmgenomics Pers Med
August 2025
Department of Oncology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, 441000, People's Republic of China.
Background: KRAS mutations are typically mutually exclusive in non-small cell lung cancer (NSCLC), with the G12C mutation being the most common subtype. The coexistence of KRAS and EGFR mutations is exceedingly rare and is typically emerges as a secondary event following acquired resistance to EGFR-targeted therapies. We presented a case of a newly diagnosed NSCLC patient harboring concurrent EGFR L858R and KRAS G12A mutations.
View Article and Find Full Text PDFOsteoporos Int
August 2025
Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Unlabelled: Low bone mineral density (BMD) increases fracture risk, poor life-quality, and death. Low BMD is prevalent in tobacco-exposed individuals with lung disease; however, they are not included in current screening guidelines. In our study, a majority of individuals with former tobacco exposure not meeting current screening criteria had low BMD.
View Article and Find Full Text PDF